Hester Biosciences Ltd vs Ind Swift Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Hester Biosciences Ltd is ₹ 1638 as of 30 Apr 15:30 . The P/E Ratio of Hester Biosciences Ltd changed from 47.4 on March 2021 to 38.8 on March 2025 . This represents a CAGR of -3.92% over 5 yearsThe P/E Ratio of Ind-Swift Laboratories Ltd changed from 6.9 on March 2023 to 2.3 on March 2025 . This represents a CAGR of -30.66% over 3 years The Market Cap of Hester Biosciences Ltd changed from ₹ 1630 crore on March 2021 to ₹ 1066 crore on March 2025 . This represents a CAGR of -8.14% over 5 yearsThe Market Cap of Ind-Swift Laboratories Ltd changed from ₹ 425.72 crore on March 2021 to ₹ 509.08 crore on March 2025 . This represents a CAGR of 3.64% over 5 years The revenue of Hester Biosciences Ltd for the Dec '25 is ₹ 79.4 crore as compare to the Sep '25 revenue of ₹ 82.85 crore. This represent the decline of -4.16% The revenue of Ind-Swift Laboratories Ltd for the Dec '25 is ₹ 178.43 crore as compare to the Sep '25 revenue of ₹ 170.5 crore. This represent the growth of 4.65% The ebitda of Hester Biosciences Ltd for the Dec '25 is ₹ 19.78 crore as compare to the Sep '25 ebitda of ₹ 23.6 crore. This represent the decline of -16.19% The ebitda of Ind-Swift Laboratories Ltd for the Dec '25 is ₹ 25.9 crore as compare to the Sep '25 ebitda of ₹ 19.34 crore. This represent the growth of 33.92% The net profit of Hester Biosciences Ltd changed from ₹ 7.49 crore to ₹ 9.31 crore over 7 quarters. This represents a CAGR of 13.24% The net profit of Ind-Swift Laboratories Ltd changed from ₹ 1.01 crore to ₹ 9.52 crore over 7 quarters. This represents a CAGR of 260.37% The Dividend Payout of Hester Biosciences Ltd changed from 21.33 % on March 2021 to 18.71 % on March 2025 . This represents a CAGR of -2.59% over 5 yearsThe Dividend Payout of Ind-Swift Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Hester Biosciences Ltd

Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India.
The Company was incorporated in April, 1987 and is engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal and Petcare health products having its manufacturing set up at Meda Adraj Village, Mehsana District, Gujarat. The Company built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh.
The products and services included over 51 vaccines and 70+ health products.
In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals. The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents.

About Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Limited is a part of the Ind-Swift Group and is based at Chandigarh, Punjab, India.
The Company is one of the leading manufacturers of APIs catering to global and domestic formulators.
Based in Chandigarh, India, the Company operated two advanced manufacturing facilities in Derabassi and Jammu, adhering to international standards.
Ind-Swift Laboratories Ltd. is recognised globally as a leader in the Macrolide Antibiotic sector, and its products are well-regarded by major pharmaceutical formulators worldwide. Ind-Swift Laboratories Limited was incorporated on January 4, 1995 as a joint venture between Ind-Swift Ltd and Punjab State Industrial Development Corporation.
Later, Ind-Swift purchased Punjab State Industrial Development Corporation equity to emerge as a single largest shareholder in the company.

FAQs for the comparison of Hester Biosciences Ltd and Ind-Swift Laboratories Ltd

Which company has a larger market capitalization, Hester Biosciences Ltd or Ind-Swift Laboratories Ltd?

Market cap of Hester Biosciences Ltd is 1,393 Cr while Market cap of Ind-Swift Laboratories Ltd is 1,190 Cr

What are the key factors driving the stock performance of Hester Biosciences Ltd and Ind-Swift Laboratories Ltd?

The stock performance of Hester Biosciences Ltd and Ind-Swift Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hester Biosciences Ltd and Ind-Swift Laboratories Ltd?

As of May 4, 2026, the Hester Biosciences Ltd stock price is INR ₹1638.3. On the other hand, Ind-Swift Laboratories Ltd stock price is INR ₹137.15.

How do dividend payouts of Hester Biosciences Ltd and Ind-Swift Laboratories Ltd compare?

To compare the dividend payouts of Hester Biosciences Ltd and Ind-Swift Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.